We serve Chemical Name:6-chloro-4-methyl-1,3-benzothiazol-2-amine CAS:38338-21-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-chloro-4-methyl-1,3-benzothiazol-2-amine
CAS.NO:38338-21-5
Synonyms:6-Chloro-4-methyl-benzothiazol-2-ylamine;6-Chlor-4-methyl-benzothiazol-2-ylamin;6-chloro-4-methylbenzothiazole-2-ylamine;F1911-0023
Molecular Formula:C8H7ClN2S
Molecular Weight:198.67300
HS Code:2934200090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:360.3ºC at 760 mmHg
Density:1.452g/cm3
Index of Refraction:1.728
PSA:67.15000
Exact Mass:198.00200
LogP:3.42150
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-Chloro-4-methyl-benzothiazol-2-ylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,F1911-0023 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,F1911-0023 Use and application,6-Chlor-4-methyl-benzothiazol-2-ylamin technical grade,usp/ep/jp grade.
Related News: The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers. 6-chloro-4-methyl-1,3-benzothiazol-2-amine manufacturer The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. 6-chloro-4-methyl-1,3-benzothiazol-2-amine supplier The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers. 6-chloro-4-methyl-1,3-benzothiazol-2-amine vendor The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. 6-chloro-4-methyl-1,3-benzothiazol-2-amine factory The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.
